M

Medy Tox Inc
KOSDAQ:086900

Watchlist Manager
Medy Tox Inc
KOSDAQ:086900
Watchlist
Price: 122 400 KRW 1.32% Market Closed
Market Cap: 893.5B KRW

Wall Street
Price Targets

Price Targets Summary
Medy Tox Inc

Wall Street analysts forecast Medy Tox Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Medy Tox Inc is 135 320 KRW with a low forecast of 111 100 KRW and a high forecast of 155 400 KRW.

Lowest
Price Target
111 100 KRW
9% Downside
Average
Price Target
135 320 KRW
11% Upside
Highest
Price Target
155 400 KRW
27% Upside
Medy Tox Inc Competitors:
Price Targets
688363
Bloomage Biotechnology Corp Ltd
10% Upside
ZYME
Zymeworks Inc
38% Upside
EXAS
Exact Sciences Corp
1% Downside
IMTX
Immatics NV
80% Upside
NTLA
Intellia Therapeutics Inc
140% Upside
688235
Beigene Ltd
38% Upside
005690
Pharmicell Co Ltd
17% Upside
ATRA
Atara Biotherapeutics Inc
11% Upside

Revenue
Forecast

Revenue Estimate
Medy Tox Inc

For the last 11 years the compound annual growth rate for Medy Tox Inc's revenue is 17%. The projected CAGR for the next 3 years is 12%.

17%
Past Growth
12%
Estimated Growth
Estimates Accuracy
0%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Medy Tox Inc

For the last 11 years the compound annual growth rate for Medy Tox Inc's operating income is 2%. The projected CAGR for the next 3 years is 53%.

2%
Past Growth
53%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
Medy Tox Inc

For the last 11 years the compound annual growth rate for Medy Tox Inc's net income is 1%. The projected CAGR for the next 3 years is 57%.

1%
Past Growth
57%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Medy Tox Inc's stock price target?
Price Target
135 320 KRW

According to Wall Street analysts, the average 1-year price target for Medy Tox Inc is 135 320 KRW with a low forecast of 111 100 KRW and a high forecast of 155 400 KRW.

What is Medy Tox Inc's Revenue forecast?
Projected CAGR
12%

For the last 11 years the compound annual growth rate for Medy Tox Inc's revenue is 17%. The projected CAGR for the next 3 years is 12%.

What is Medy Tox Inc's Operating Income forecast?
Projected CAGR
53%

For the last 11 years the compound annual growth rate for Medy Tox Inc's operating income is 2%. The projected CAGR for the next 3 years is 53%.

What is Medy Tox Inc's Net Income forecast?
Projected CAGR
57%

For the last 11 years the compound annual growth rate for Medy Tox Inc's net income is 1%. The projected CAGR for the next 3 years is 57%.

Back to Top